Final results of the DisCoVeRy trial of remdesivir for patients admitted to hospital with COVID-19.
Lancet Infect Dis
; 22(6): 764-765, 2022 06.
Article
in English
| MEDLINE | ID: covidwho-1864681
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Adenosine Monophosphate
/
Alanine
/
COVID-19 Drug Treatment
Type of study:
Prognostic study
/
Randomized controlled trials
Limits:
Humans
Language:
English
Journal:
Lancet Infect Dis
Journal subject:
Communicable Diseases
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS